Perceval S sutureless valve for aortic valve replacement a review of the clinical effectiveness, safety, and cost-effectiveness
The Perceval S sutureless valve consists of a bioprosthetic valve mounted on a self-expanding nitinol stent. It received European regulatory approval in January 2013, and is currently undergoing US registration trials. In Canada it is available on a named-patient basis through the Health Canada spec...
Corporate Authors: | , |
---|---|
Format: | eBook |
Language: | English |
Published: |
[Ottawa]
Canadian Agency for Drugs and Technologies in Health
29 January 2015, 2015
|
Series: | Rapid response report: summary with critical appraisal
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | The Perceval S sutureless valve consists of a bioprosthetic valve mounted on a self-expanding nitinol stent. It received European regulatory approval in January 2013, and is currently undergoing US registration trials. In Canada it is available on a named-patient basis through the Health Canada special access program. This report reviews the evidence for the effectiveness, safety and cost effectiveness for the Perceval S sutureless valve for patients with aortic stenosis |
---|---|
Item Description: | "CADTH Rapid Response Service." |
Physical Description: | 1 PDF file (33 pages) |